Skip to main content

Find Clinical Trials

Home
Conditions
Stage IIIA Breast Cancer

Clinical trial condition

Stage IIIA Breast Cancer

Explore clinical trials studying Stage IIIA Breast Cancer. Study availability and eligibility vary by location and protocol.

102 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIA Breast Cancer trial results

Completed

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

NCT01417286

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +22 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

Huntsman Cancer Hospital Salt Lake City, Utah, United States

View Trial Details

Completed

Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer

NCT02432950

Conditions: Body Weight, Breast Diseases, Breast Neoplasms, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors

NCT02235051

Conditions: Breast Diseases, Breast Neoplasms, Cancer Survivor, +11 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

NCT01478477

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +10 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03

NCT04109391

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Tanvex Investigational Site 1006E Grodno, Belarus

Tanvex Investigational Site 1003E Homyel, Belarus

Tanvex Investigational Site 1008E Lesnoy, Belarus

Tanvex Investigational Site 1002E Minsk, Belarus

View all 86 locations

View Trial Details

Completed

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

NCT02728596

Conditions: Agranulocytosis, Breast Carcinoma In Situ, Breast Diseases, +60 more
Locations: Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States

Contra Costa Regional Medical Center Martinez, California, United States

Augusta University Medical Center Augusta, Georgia, United States

View all 160 locations

View Trial Details

Completed

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

NCT03364348

Conditions: Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +10 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

NCT03050463

Conditions: Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +17 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors

NCT03039140

Conditions: Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +17 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

NCT03556358

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Tanvex Investigational Site 1008 Lyasny, Minsk Oblast, Belarus

Tanvex Investigational Site 1007 Babruysk, Mogilyov Oblast, Belarus

Tanvex Investigational Site 1006 Grodno, Belarus

Tanvex Investigational Site 1003 Homyel, Belarus

View all 146 locations

View Trial Details